AYTU BIOPHARMA, INC. (AYTU) scores 59 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is 1.3, representing a 50% premium to fair value. Quantitative score: 66/100. Qualitative score: 50/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.